Pantheon International PLC

Specialist

Rated Fund 2013-19. A fund-of-funds approach with a spread of risk and reward

Pantheon International was launched in 1987, making it the UK’s longest-established private equity fund of funds. It has grown from £12 million at launch to £1.4 billion today.

Since its inception, it has generated average annual net asset value per share growth of 11.9%, outperforming both the FTSE All-Share (7.8%) and MSCI World (7.9%) indices.

The lead manager is Andrew Lebus, who heads a team of 80 investment professionals. He actively manages risk by carefully selecting high-quality private equity managers to create a balanced portfolio that is diversified by geography, investment stage and sector. Exposure is balanced across buyout, venture and growth, and special situations funds.

Some 43% of the portfolio is invested in secondary investments (buying interests from other investors), which allow the managers to maintain a mature portfolio profile and benefit from the cash distributions that gives the trust its financial strength and investment pace.

Co-investments (participating directly in the purchase of a portfolio company investment alongside a private equity fund) have increased in recent years, from 3% in 2013 to 32% today. These are undertaken alongside private equity managers that are already known to Pantheon and have successful track records of managing assets through economic cycles. The balance is in primary investments (investing in a new fund when it is established).

At the end of 2018, the portfolio was weighted towards the US (56%) and Europe (25%). Its shares have traded on a discount to net assets as wide as 30% and as narrow as 12% in the past three years.

Narrative and ratings content all as of 01 January 2019.

See all Money Observer rated funds
Name
Pantheon International PLC
Manager
Pantheon Ventures (UK) LLP
Type
Closed Ended Investment Company
ISIN
GB0004148507
Sector
Private Equity
Launched
18/09/1987
OCF
1.23 %
Risk Rating
1
3 Year Sharpe
1.39
3 Year Alpha
7.48
Yield
0 %
Benchmark
MSCI World GR USD
Fund Size
£ 1.24 billion
NAV
2,949
Gearing
91
Discount Premium
-22
To maximise capital growth by investing in funds specialising in unquoted investments, acquiring existing unquoted portfolios and participating directly in private placements. The Company's policy is to make unquoted investments, in general by subscribing for investments in new private equity funds ("Primary Investment") and by buying secondary interests in existing private equity funds ("Secondary Investment"), and from time to time to capitalise further on its fund investment activities by acquiring direct holdings in unquoted companies ("Co-investments"), usually either where a vendor is seeking to sell a combined portfolio of fund interests and direct holdings or where there is a private equity manager, well known to the Company's Manager, investing on substantially the same terms.
Holding %
Confidential 7.20 %
Eusa Pharma 2.20 %
Abacus Data Systems 1.20 %
StandardAero 1.00 %
Adyen NV 1.00 %
LBX Pharmacy Chain JSC 0.80 %
Permian Res 0.80 %
Orangefield Group 0.70 %
Sivantos 0.70 %
Kyobo Life Insurance 0.60 %
Region %
United States 44.44 %
Eurozone 25.93 %
United Kingdom 14.81 %
Asia - Emerging 14.81 %
Sector %
Consumer Defensive 30.95 %
Technology 23.81 %
Financial Services 16.67 %
Energy 16.67 %
Consumer Cyclical 11.90 %
Name
Pantheon Ventures (UK) LLP
Address
EC2A1AF, London, United Kingdom
UCITS
No
Legal Structure
Closed Ended Investment Company

Managers

Andrew Lebus
Joined 07/31/2002

Data provided by Morningstar.

The Content is only for your general information and use and is not intended to address your particular requirements. The Content does not constitute any form of advice, recommendation or arrangement by Money Observer and is not intended to be relied upon by you in making (or refraining from making) any specific investment or other decisions. Appropriate independent advice should be obtained before making any such decision.

This information is sourced from our partner Morningstar. We believe the data to be correct however you should take care in using any information.

You should be aware that prices may fall as well as rise and that the income derived can go down as well as up. When buying or selling any investment that fluctuates in price or value you may get back less than you invested. Past performance is not necessarily a guide to future performance.